Skip to main content

Pefloxacin (International)



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Fluoroquinolone (gyrase inhibitor)

Chemical Names

1-Etyl-6-fluor-7-(4-metyl-1-piperazin-1-yl)-4-oxo-1,4-dihydrochinolin-3-carbonsäure (IUPAC)

1-Etyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-metyl-1-piperazinyl)-3-quinolinecarboxylic acid

1-Etyl-6-fluoro-1,4-dihydro-7-(4-metyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid (WHO)

3-Quinolinecarboxylic acid, 1,4-dihydro-1-etyl-6-fluoro-7-(4-metyl-1-piperazinyl)-4-oxo-

3-Quinolinecarboxylic acid, 1-etyl-6-fluoro-1,4-dihydro-7-(4-metyl-1-piperazinyl)-4-oxo-

Foreign Names

  • Pefloxacinum (Latin)
  • Pefloxacin (German)
  • Péfloxacine (French)
  • Pefloxacino (Spanish)

Generic Names

  • Pefloxacin (OS: USAN, BAN)
  • Pefloxacina (OS: DCIT)
  • Péfloxacine (OS: DCF)
  • EU 5306 (IS)
  • RB 1589 (RogerBellon) (IS)
  • Pefloxacin Mesilate (OS: BAN)
  • Pefloxacin Mesylate (OS: USAN)
  • RP 41982 (RhônePoulenc) (IS)
  • Pefloxacin Mesilate (PH: BP 2018)
  • Pefloxacin mesilate dihydrate (PH: Ph. Eur. 9)
  • Péfloxacine (mésilate de) dihydraté (PH: Ph. Eur. 9)
  • Pefloxacini mesilas dihydricus (PH: Ph. Eur. 9)
  • Pefloxacinmesilat-Dihydrat (PH: Ph. Eur. 9)

Brand Names

  • Abaktal
    Lek, Lithuania; Lek, Pakistan; Lek, Slovenia; Sandoz, Poland; Sandoz, Slovakia
  • Dexaflox
    Dexa Medica, Indonesia
  • Euphen
    Sami, Pakistan
  • Evequin
    Everest, Pakistan
  • Floxpe
    Lowitt, Pakistan
  • Globacin
    GNP, Egypt
  • G-Pefloxacine
    Gonoshasthaya, Bangladesh
  • Gramocin
    Medicaids, Pakistan
  • Isofloxin
    Beximco, Bangladesh
  • Kroject
    Adfa, Pakistan
  • Neoflox
    Pharmix, Pakistan
  • Neolox
    Siza, Pakistan
  • Nobac
    Ibn Sina, Bangladesh
  • Noflexin
    Novell Pharmaceutical, Indonesia
  • Oxaflox
    Coronet Crown, Indonesia
  • Peflacin
    Famar, Lebanon
  • Peflacine
    Bellon, Kuwait; Eczacibasi, Turkey; Sanofi-Aventis, Bangladesh
  • Peflobid
    Cadila, India
  • Peflon
    GlaxoSmithKline, Bangladesh
  • Peflox
    Drug International, Bangladesh; top ph, Egypt
  • Pefloxacin Laropharm
    Laropharm, Romania
  • Pelox
    Wockhardt, Egypt
  • Perti
    Dr. Reddy's, India
  • Piflasyn
    AHPL, India
  • Susceptin
    Zad, Egypt
  • Abaktal
    LEK farmacevtska, Macedonia; Lek Pharmaceuticals, Czech Republic; Sandoz, Poland; Sandoz, Russian Federation
  • Beining
    Zhi Jun Pharm, China
  • Da Fu Ming
    CR Double-Crane, China
  • Dian Sha
    QiLi Pharmaceutical, China
  • Felox
    Gracia Pharmindo, Indonesia
  • Floxol
    Duopharma M Sdn Bhd, Philippines
  • Labocton
    Viofar, Greece
  • Peflacin
    Sanofi-Aventis, Italy
  • Peflacina
    Sanofi-Aventis, Mexico
  • Peflacine
    Sanofi-Aventis, Indonesia
  • Peflox
    Formenti, Italy
  • Peloxin I.V.
    Panbiotic, Taiwan
  • Peraxin
    Korea United Pharma, Philippines
  • Pexacin I.V.
    Siu Guan, Taiwan
  • Wei Li Ke
    Sine Pharmaceutical, China
  • Wei Ning Jia
    TaiYuan Pharmaceutical, China


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.